These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37451517)

  • 1. HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs.
    Darlington CK; Lipsky RK; Teitelman AM; Koblin BA; Davis A; Walcott M; Compton PA; Tieu HV
    J Subst Use Addict Treat; 2023 Sep; 152():209119. PubMed ID: 37451517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related factors associated with intention to initiate pre-exposure prophylaxis among cisgender women in Washington D.C.
    Zack JL; Hull SJ; Coleman ME; Ye PP; Lotke PS; Visconti A; Beverley J; Brant A; Moriarty P; Scott RK
    Ther Adv Infect Dis; 2024; 11():20499361241252351. PubMed ID: 38751758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City.
    Scott RK; Hull SJ; Huang JC; Ye PP; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Elion R; Visconti AJ; Coleman M
    Womens Health Issues; 2023; 33(5):541-550. PubMed ID: 37479630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C.
    Scott RK; Hull SJ; Huang JC; Coleman M; Ye P; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Cameron M; Elion R; Visconti A
    Arch Sex Behav; 2022 Jul; 51(5):2613-2624. PubMed ID: 35622077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "I think everybody should take it if they're doing drugs, doing heroin, or having sex for money": a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program.
    Przybyla SM; Cerulli C; Bleasdale J; Wilson K; Hordes M; El-Bassel N; Morse DS
    Subst Abuse Treat Prev Policy; 2020 Nov; 15(1):89. PubMed ID: 33228721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial.
    Goddard-Eckrich D; McCrimmon T; Bond K; Chang M; Hunt T; Hall J; Russo M; Ramesh V; Johnson KA; Downey DL; Wu E; El-Bassel N; Gilbert L
    Addict Sci Clin Pract; 2024 Jul; 19(1):55. PubMed ID: 39039560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Moderating Effects of HIV Relevant Factors on the Relationship Between Intimate Partner Violence and Intention to Start HIV Pre-exposure Prophylaxis (PrEP) Among Cisgender Women.
    Keddem S; Frye V; Davis A; Koblin BA; Tieu HV; Lipsky RK; Nandi V; Teitelman AM
    Arch Sex Behav; 2024 Apr; 53(4):1531-1539. PubMed ID: 38366311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness, acceptability, and intention to initiate HIV pre-exposure prophylaxis among pregnant women.
    Scott RK; Hull SJ; Richards RC; Klemmer K; Salmoran F; Huang JC
    AIDS Care; 2022 Feb; 34(2):201-213. PubMed ID: 33874801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beliefs Associated with Intention to Use PrEP Among Cisgender U.S. Women at Elevated HIV Risk.
    Teitelman AM; Chittamuru D; Koblin BA; Davis A; Brawner BM; Fiore D; Broomes T; Ortiz G; Lucy D; Tieu HV
    Arch Sex Behav; 2020 Aug; 49(6):2213-2221. PubMed ID: 32270399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-exposure Prophylaxis (PrEP) Initiation Among Black and Latina Cisgender Women Receiving HIV Prevention Care Coordination Services in New York City.
    Cheek JB; Feldman MB; Montero N; Gambone GF; Hoffman S; Blackstock OJ
    AIDS Behav; 2022 Oct; 26(10):3174-3184. PubMed ID: 35362904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where's the "Everyday Black Woman"? An intersectional qualitative analysis of Black Women's decision-making regarding HIV pre-exposure prophylaxis (PrEP) in Mississippi.
    Willie TC; Knight D; Baral SD; Chan PA; Kershaw T; Mayer KH; Stockman JK; Adimora AA; Monger M; Mena LA; Philllips KA; Nunn A
    BMC Public Health; 2022 Aug; 22(1):1604. PubMed ID: 35999528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Just4Us: Development of a Counselor-Navigator and Text Message Intervention to Promote PrEP Uptake Among Cisgender Women at Elevated Risk for HIV.
    Teitelman AM; Koblin BA; Brawner BM; Davis A; Darlington C; Lipsky RK; Iwu E; Bond KT; Westover J; Fiore D; Tieu HV
    J Assoc Nurses AIDS Care; 2021 Mar-Apr 01; 32(2):188-204. PubMed ID: 33427767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
    Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
    PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system.
    Rutledge R; Madden L; Ogbuagu O; Meyer JP
    AIDS Care; 2018 Oct; 30(10):1282-1289. PubMed ID: 29527934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal HIV Pre-exposure Prophylaxis Awareness and Willingness to Use Among Women Who Use Drugs in the United States: A Systematic Review and Meta-analysis.
    Zhang C; McMahon J; Simmons J; Brown LL; Nash R; Liu Y
    AIDS Behav; 2019 Oct; 23(10):2641-2653. PubMed ID: 31297684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention.
    Jackson GY; Darlington CK; Van Tieu H; Brawner BM; Flores DD; Bannon JA; Davis A; Frye V; Chittamuru D; Gugerty P; Koblin BA; Teitelman AM
    Cult Health Sex; 2022 May; 24(5):642-656. PubMed ID: 33535887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey with interventional components delivered on tablet devices versus usual care to increase pre-exposure prophylaxis uptake among cisgender Black women: a pilot randomized controlled trial.
    Hill MJ; Heads AM; Suchting R; Stotts AL
    BMC Infect Dis; 2023 Jan; 23(1):57. PubMed ID: 36707778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early pre-exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South Africa.
    Joseph Davey DL; Mvududu R; Mashele N; Lesosky M; Khadka N; Bekker LG; Gorbach P; Coates TJ; Myer L
    J Int AIDS Soc; 2022 Feb; 25(2):e25866. PubMed ID: 35138678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
    Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
    Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intention to initiate and uptake of PrEP among women who injects drugs in a demonstration project: an application of the theory of planned behavior.
    Tran NK; Felsher M; Pol BV; Bellamy SL; McKnight J; Roth AM
    AIDS Care; 2021 Jun; 33(6):746-753. PubMed ID: 33486981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.